Hepatocyte growth factor in cerebrospinal fluid is associated with mortality and recurrence of glioblastoma, and could be of prognostic value

Journal of Neuro-Oncology

Volumn 97, Issue 3, 2010, Pages 347-351

  Garcia Navarrete, Roberto ^a   Garcia, Esperanza ^a   Arrieta, Oscar ^b   Sotelo, Julio ^a  

^a Neuroimmunology Unit   (Mexico)

^b Instituto Nacional de Cancerologi'a de México   (Mexico)

Author keywords

Cancer; HGF; Malignant glioma; Prognosis; Survival

Indexed keywords

SCATTER FACTOR;

ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MENINGIOMA; PROGNOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; SURVIVAL TIME;

ADULT; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HEPATOCYTE GROWTH FACTOR; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED;

EID: 77953287543     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-0037-8     Document Type: Article

References (28)

1. Abounader R, Laterra J (2005) Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro Oncol 7(4):436-451
2. Chu SH, Yuan XH, Jiang PC, Li ZQ, Zhang J, Wen ZH, Zhao SY, Chen XJ, Cao CJ (2005) The expression of hepatocyte growth factor and its receptor in brain astrocytomas. Zhonghua Yi Xue Za Zhi 85(12):835-838 (Pubitemid 40484874)
3. Guerin C, Luddy C, Abounader R, Lal B, Laterra J (2000) Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor. Biochem Biophys Res Commun 273(1):287-293
4. Moriyama T, Kataoka H, Kawano H, Yokogami K, Nakano S, Goya T, Uchino H, Koono M, Wakisaka S (1998) Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. Cancer Lett 124(2):149-155
5. Stiver SI (2004) Angiogenesis and its role in the behavior of astrocytic brain tumors. Front Biosci 9:3105-3123
6. Uchinokura S, Miyata S, Fukushima T, Itoh H, Nakano S, Wakisaka S, Kataoka H (2006) Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo. Int J Cancer 118(3):583-592
7. Karcher S, Steiner HH, Ahmadi R, Zoubaa S, Vasvari G, Bauer H, Unterberg A, Herold-Mende C (2006) Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer 118(9):2182-2189
8. Moriyama T, Kataoka H, Hamasuna R, Yokogami K, Uehara H, Kawano H, Goya T, Tsubouchi H, Koono M, Wakisaka S (1998) Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem Biophys Res Commun 249(1):73-77
9. Schmidt NO, Westphal M, Hagel C, Ergün S, Stavrou D, Rosen EM, Lamszus K (1999) Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer 84(1):10-18
10. Steiner HH, Karcher S, Mueller MM, Nalbantis E, Kunze S, Herold-Mende C (2004) Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: clinical relevance of radiation-induced increase of VEGF levels. J Neurooncol 66(1-2):129-138
11. Koochekpour S, Jeffers M, Rulong S, Taylor G, Klineberg E, Hudson EA, Resau JH, Vande Woude GF (1997) Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res 57(23):5391-5398
12. Kunkel P, Müller S, Schirmacher P, Stavrou D, Fillbrandt R, Westphal M, Lamszus K (2001) Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas. Neuro Oncol 3(2):82-88
13. Lamszus K, Laterra J, Westphal M, Rosen EM (1999) Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int J Dev Neurosci 17(5-6):517-530
14. Laterra J, Rosen E, Nam M, Ranganathan S, Fielding K, Johnston P (1997) Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. Biochem Biophys Res Commun 235(3):743-747 (Pubitemid 27326555)
15. Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R (2005) The scatter factor/ hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Cancer Res 65(20):9355-9362
16. Moriyama T, Kataoka H, Koono M, Wakisaka S (1999) Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review). Int J Mol Med 3(5):531-536
17. Reznik TE, Sang Y, Ma Y, Abounader R, Rosen EM, Xia S, Laterra J (2008) Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. Mol Cancer Res 6(1):139-150
18. Badie B, Schartner J, Klaver J, Vorpahl J (1999) In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. Neurosurgery 44(5): 1077-1082
19. Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J (2002) In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. FASEB J 16(1):108-110
20. Arrieta O, Garcia E, Guevara P, Garcia-Navarrete R, Ondarza R, Rembao D, Sotelo J (2002) Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. Cancer 94(12):3210-3218
21. Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P, Laterra J (1999) Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J Natl Cancer Inst 91(18):1548-1556
22. Brockmann MA, Papadimitriou A, Brandt M, Fillbrandt R, Westphal M, Lamszus K (2003) Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4. Clin Cancer Res 9(12):4578-4585
23. Burgess T, Coxon A, Meyer S, Sun J, Rex K, Tsuruda T, Chen Q, Ho SY, Li L, Kaufman S, McDorman K, Cattley RC, Sun J, Elliott G, Zhang K, Feng X, Jia XC, Green L, Radinsky R, Kendall R (2006) Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors. Cancer Res 66(3):1721-1729
24. Cao B, Su Y, Oskarsson M, Zhao P, Kort EJ, Fisher RJ, Wang LM, Vande Woude GF (2001) Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc Natl Acad Sci USA 98(13):7443-7448
25. Chu SH, Zhu ZA, Yuan XH, Li ZQ, Jiang PC (2006) In vitro and in vivo potentiating the cytotoxic effect of radiation on human U251 gliomas by the c-Met antisense oligodeoxynucleotides. J Neurooncol 80(2):143-149
26. Kim KJ, Wang L, Su YC, Gillespie GY, Salhotra A, Lal B, Laterra J (2006) Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Clin Cancer Res 12(4):1292-1298
27. Lal B, Xia S, Abounader R, Laterra J (2005) Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation. Clin Cancer Res 11(12):4479-4486
28. Martens T, Schmidt NO, Eckerich C, Fillbrandt R, Merchant M, Schwall R, Westphal M, Lamszus K (2006) A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo. Clin Cancer Res 12(20 Pt 1):6144-6152